RR&D Gordon Mansfield Spinal Cord Injury Consortium
RR
基本信息
- 批准号:10538563
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-07-01 至 2025-12-31
- 项目状态:未结题
- 来源:
- 关键词:AnatomyAxonBilateralBiodistributionBrainCaliforniaCellsCentral Nervous SystemCervical spinal cord injuryCervical spinal cord structureChronicClinicalClinical TrialsCollaborationsCombined Modality TherapyContusionsDataDevelopmentES Cell LineForelimbFundingGraft SurvivalGrantHumanHuman Cell LineInjuryInterventionInvestigational TherapiesInvestmentsLaboratoriesLeadLesionLifeLower ExtremityMacaca mulattaMeasuresMediatingMedical centerModelingMonkeysNatural regenerationNeuronal PlasticityNeuronsOutcomePainPathologistPersonsPrimatesRattusReadinessRecoveryRecovery of FunctionRehabilitation deviceRehabilitation therapyReproducibilityResearchResearch PersonnelRoboticsRodentSafetySamplingSan FranciscoScientistSiteSpinalSpinal CordSpinal Cord ContusionsSpinal cord injurySynapsesTechnologyToxic effectTrainingTranslatingTranslationsUpper ExtremityValidationVertebral columnVeteransWorkaxon regenerationaxonal sproutingclinically relevantdesigneffective therapyefficacy studyefficacy testingexperimental studyfunctional improvementfunctional outcomesgrasphand rehabilitationhuman embryonic stem cellhuman embryonic stem cell lineimprovedin vivo evaluationinjury and repairinnovationlead candidatenerve stem cellneuralneural circuitneurological recoveryneuroregulationnonhuman primateoperationprogramsrehabilitation paradigmrehabilitation strategyrepairedsafety studyskillsspasticitystem cell biologystem cell survivalstem cell therapystem cellssynaptogenesissynergismtherapy development
项目摘要
This project aims to develop a neural stem cell (NSC) therapy to repair the injured spinal cord
and support functional recovery. In the proposed work, we aim to advance this program to an
IND-enabling stage. Moreover, we aim to continue to develop and optimize potential stem cell
therapies for spinal cord injury (SCI) by examining combinations of innovative rehabilitation and
spinal cord neuromodulation strategies with neural stem cell therapies to potentially amplify
stem cell-mediated recovery of function. Finally, we aim to invest substantial effort to assess
NSC efficacy in chronic SCI.
This work focuses on human NSCs derived from a federally “approved” human embryonic stem
cell (ESC) line, the H9 ESC line. The studies we propose herein will primarily use clinically
relevant spinal cord injury contusion models. Independent replication by an investigator outside
this consortium of scientists will be conducted.
Notably, this is an intensely collaborative effort among leading laboratories researching spinal
cord injury, including the Tuszynski group at the San Diego VA Medical Center and UCSD
(includes Drs. Rosenzweig, Lu and Brock); the Beattie/Bresnahan/Ferguson group at the San
Francisco VA Medical Center and UCSF; the Reinkensmeyer lab at UC Irvine; the Havton lab at
UCLA; the California National Primate Research Center located at UC Davis; and the Courtine
lab at the Swiss Federal Institute of Technology. Experiments have been collectively designed
and performed by this consortium, an unprecedented effort in SCI research to advance the field
through close collaboration and interaction on jointly performed experiments. Throughout, this
project will benefit from a free exchange of information among the collaborators.
该项目旨在开发神经干细胞(NSC)治疗以修复受伤的脊髓
并支持功能恢复。在拟议的工作中,我们旨在将该计划推向
成立阶段。此外,我们旨在继续开发和优化潜在的干细胞
通过检查创新康复的组合和
具有神经元干细胞疗法的脊髓神经调节策略可能会扩大
干细胞介导的功能恢复。最后,我们旨在投入大量努力来评估
慢性科学的NSC效率。
这项工作的重点是源自联邦“批准”人类胚胎的人类NSC
单元格(ESC)线,H9 ESC线。我们本文提出的研究将在临床上主要使用
相关的脊髓损伤挫伤模型。在外面的调查员独立复制
将举办这个科学家联盟。
值得注意的是,这是研究脊柱的领先实验室的内在协作努力
绳索损伤,包括圣地亚哥弗吉尼亚州医疗中心和UCSD的Tuszynski组
(包括Rosenzweig博士,Lu和Brock); San的Beattie/Bresnahan/Ferguson Group
Francisco VA医疗中心和UCSF; UC Irvine的Reinkensmeyer实验室;哈夫顿实验室
ucla;位于加州大学戴维斯分校的加利福尼亚国家灵长类动物研究中心;和法庭
瑞士联邦技术学院的实验室。实验已被集体设计
并由该财团进行,这是SCI研究中前所未有的努力来推进该领域
通过在共同执行的实验上进行密切合作和互动。在整个过程中
项目将受益于合作者之间的免费信息。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Comprehensive Monosynaptic Rabies Virus Mapping of Host Connectivity with Neural Progenitor Grafts after Spinal Cord Injury.
- DOI:10.1016/j.stemcr.2017.04.004
- 发表时间:2017-06-06
- 期刊:
- 影响因子:5.9
- 作者:Adler AF;Lee-Kubli C;Kumamaru H;Kadoya K;Tuszynski MH
- 通讯作者:Tuszynski MH
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARK H. TUSZYNSKI其他文献
MARK H. TUSZYNSKI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARK H. TUSZYNSKI', 18)}}的其他基金
Advancing human neural progenitor cells (hNPCs) to FDA IND approval
推动人类神经祖细胞 (hNPC) 获得 FDA IND 批准
- 批准号:
10642228 - 财政年份:2023
- 资助金额:
-- - 项目类别:
The Primate Corticospinal Connectome and Transcriptome - Supplement
灵长类动物皮质脊髓连接组和转录组 - 补充
- 批准号:
10876189 - 财政年份:2023
- 资助金额:
-- - 项目类别:
A Clinical Trial of AAV2-BDNF Gene Therapy in Alzheimer's Disease
AAV2-BDNF 基因治疗阿尔茨海默病的临床试验
- 批准号:
10663796 - 财政年份:2021
- 资助金额:
-- - 项目类别:
A Clinical Trial of AAV2-BDNF Gene Therapy in Alzheimer's Disease
AAV2-BDNF 基因治疗阿尔茨海默病的临床试验
- 批准号:
10185291 - 财政年份:2021
- 资助金额:
-- - 项目类别:
A Clinical Trial of AAV2-BDNF Gene Therapy in Alzheimer's Disease
AAV2-BDNF 基因治疗阿尔茨海默病的临床试验
- 批准号:
10402369 - 财政年份:2021
- 资助金额:
-- - 项目类别:
ShEEP request for a Zeiss LSM 880 with Airyscan confocal system
ShEEP 请求配备 Airyscan 共焦系统的 Zeiss LSM 880
- 批准号:
9573958 - 财政年份:2018
- 资助金额:
-- - 项目类别:
The Primate Corticospinal Connectome and Transcriptome
灵长类动物皮质脊髓连接组和转录组
- 批准号:
10386916 - 财政年份:2017
- 资助金额:
-- - 项目类别:
The Primate Corticospinal Connectome and Transcriptome
灵长类动物皮质脊髓连接组和转录组
- 批准号:
10211059 - 财政年份:2017
- 资助金额:
-- - 项目类别:
The Primate Corticospinal Connectome and Transcriptome
灵长类动物皮质脊髓连接组和转录组
- 批准号:
10650134 - 财政年份:2017
- 资助金额:
-- - 项目类别:
相似国自然基金
轴突CD82调控星形胶质细胞TGF-β2/Smads信号通路改善青光眼视盘结构重塑的作用及机制探究
- 批准号:82301200
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
移植并持续激活人脊髓GABA神经元对脊髓损伤后轴突再生与突触形成和运动恢复的作用
- 批准号:82301572
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA修饰通过调控轴突中mRNA局部翻译来控制轴突再生的机制研究
- 批准号:32371040
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于外泌体miR-155介导NF-κB信号通路探讨百合地黄汤调控星形胶质细胞A1/A2活化和轴突再髓鞘化的作用机制研究
- 批准号:82305079
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
异丙酚促进STX3/PTEN介导DG-Glu能神经元轴突发生提高发育脑认知功能的机制研究
- 批准号:82301354
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
The Structure and Function of Ipsilateral Corticospinal Projections
同侧皮质脊髓投射的结构和功能
- 批准号:
10678301 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Cross-modal plasticity after the loss of vision at two early developmental ages in the posterior parietal cortex: Adult connections, cortical function and behavior.
后顶叶皮质两个早期发育年龄视力丧失后的跨模式可塑性:成人连接、皮质功能和行为。
- 批准号:
10751658 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Vulnerability Profiles of Comorbid Alzheimer and TDP-43 Proteinopathies in Amnestic Dementia
遗忘性痴呆中共病阿尔茨海默病和 TDP-43 蛋白病的脆弱性概况
- 批准号:
10901010 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Encoding properties of bilateral CA3 inputs and their contribution to the formation and dynamics of CA1 spatial representations in novel environments
双边 CA3 输入的编码特性及其对新环境中 CA1 空间表示的形成和动态的贡献
- 批准号:
10510787 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Cross modal plasticity following loss of vision at different developmental stages: Cortical function, connections and compensatory behavior
不同发育阶段视力丧失后的跨模式可塑性:皮质功能、连接和补偿行为
- 批准号:
10504252 - 财政年份:2022
- 资助金额:
-- - 项目类别: